DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Henricks LM, Lunenburg CATC, de Man FM. et al.
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in
patients with cancer: A prospective safety analysis.
Lancet Oncol 2018;
19: 1459-1467
DOI: 10.1016/S1470-2045(18)30686-7.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.